[Role of macrolides in antibacterial therapy of otitis media in children].
A new macrolide vilprafen (jozamicine) was used as monotherapy or in combination with rhinopront and mucopront in 50 children with inflammation in the middle ear. Otorrhea ceased in 41 patients. Vilprafen is recommended after failure of penicilline or cephalosporine treatment, in allergic reaction to these antibiotics, in simultaneous adenoiditis and exacerbation of chronic tonsillitis.
Bogomil'skiĭ
M R
MR
Garashenko
T I
TI
D000284:Administration, Oral; D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D006801:Humans; D007223:Infant; D015570:Josamycin / Q000008:administration & dosage / Q000627:therapeutic use; D010035:Otitis Media, Suppurative / Q000188:drug therapy*; D015575:Roxithromycin / Q000008:administration & dosage / Q000627:therapeutic use; D013535:Suspensions; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D013535:Suspensions; D015575:Roxithromycin; D015570:Josamycin